Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues

Site-specific antibody conjugations generate homogeneous antibody-drug conjugates with high therapeutic index. However, there are limited examples for producing the site-specific conjugates with a drug-to-antibody ratio (DAR) greater than two, especially using engineered cysteines. Based on availabl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pharmaceuticals (Basel)
Autores principales: Zhou, Qun, Kyazike, Josephine, Boudanova, Ekaterina, Drzyzga, Michael, Honey, Denise, Cost, Robert, Hou, Lihui, Duffieux, Francis, Brun, Marie-Priscille, Park, Anna, Qiu, Huawei
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8308878/
https://ncbi.nlm.nih.gov/pubmed/34358098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14070672
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares